Vertex One Asset Management’s Gilead Sciences GILD Stock Holding History

Vertex One Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,600	Closed	-$919K	–	125
2019 Q2	$919K	Sell	13,600 -51,000	-79%	-$3.36M	0.21%	103
2019 Q1	$4.2M	Buy	64,600 +35,600	+123%	+$2.37M	0.91%	34
2018 Q4	$1.81M	Buy	29,000 +12,877	+80%	+$900K	0.53%	61
2018 Q3	$1.25M	Hold	16,123	–	–	0.19%	98
2018 Q2	$1.14M	Buy	16,123 +8,123	+102%	+$574K	0.19%	97
2018 Q1	$603K	Hold	8,000	–	–	0.11%	101
2017 Q4	$573K	Hold	8,000	–	–	0.1%	101
2017 Q3	$648K	Hold	8,000	–	–	0.11%	99
2017 Q2	$566K	Hold	8,000	–	–	0.09%	99
2017 Q1	$543K	Buy	+8,000	New	+$563K	0.09%	107

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vertex One Asset Management's GILD Position: Q3 2019 in Review

Vertex One Asset Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 13,600 shares — an estimated $919K sold.

Vertex One Asset Management first reported a position in GILD in Q1 2017 and held it in 10 quarters. The position peaked at $4.2M in Q1 2019. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

Vertex One Asset Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
Vertex One Asset Management sold 13,600 Gilead Sciences shares in Q3 2019, an estimated $919K.
Vertex One Asset Management first reported a position in Gilead Sciences in Q1 2017 and held it in 10 quarters.
Vertex One Asset Management's Gilead Sciences position peaked at $4.2M in Q1 2019.
1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Vertex One Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.